Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 5018-5033
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.5018
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.5018
Figure 1 Flow diagram of the selection procedure for the studies.
Figure 2 Hazard ratio of Bcl-2 expression associated with (A) overall survival and (B) disease free survival/recurrence free survival.
DFS: Disease free survival; RFS: Recurrence frees survival.
Figure 3 Hazard ratio of Bcl-2 expression associated with overall survival in the subgroup.
A: Patients’ number; B: Patients’ country of origin; C: The condition of treatment before surgery; D: Quality score of study.
Figure 4 Sensitivity analysis for the meta-analysis of (A) OS and (B) disease free survival/recurrence free survival in all patients.
Figure 5 Begg’s publication bias plot.
It showed no publication bias for the studies regarding the association of Bcl-2 expression with (A) OS or (B) disease free survival/recurrence free survival in the meta-analysis. Each point represents a separate study for the indicated association.
- Citation: Huang Q, Li S, Cheng P, Deng M, He X, Wang Z, Yang CH, Zhao XY, Huang J. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis. World J Gastroenterol 2017; 23(27): 5018-5033
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/5018.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.5018